December 2018 FDA Recall Estradiol Vaginal Inserts by Glenmark Pharmaceuticals Inc., Usa
D-0350-2019 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on December 26, 2018 for the product Estradiol Vaginal Inserts. The FDA reported the reason for recall as defective delivery system. The product was distributed in Product was distributed to 5 retailers and 4 distributors throughout the United States who may have further distributed the recalled product. and the recall is currently terminated.

Recall Number: D-0350-2019

Reason for Recall
Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator
Initiated
12-26-2018
Reported
01-16-2019
Quantity
96,240 applicators

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Pharmaceuticals Inc., USA
Product was distributed to 5 retailers and 4 distributors throughout the United States who may have further distributed the recalled product.
Estradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-71) and b) 18 count (NDC 68462-711-88) cartons, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale, Goa India, Manufactured for: Glenmark Pharmaceuticals, Inc., USA Mahwah, NJ

Batch or Lot Expiration Information

Batch# Batch numbers: a) 20180393, exp. date 01/31/2020, 20180424, exp. date 02/29/2020, 20180425, exp. date 02/29/2020, 20180427, exp. date 02/29/2020; b) 20180338, exp. date 12/31/2019, 20180386, exp. date 01/31/2020